PORTLAND, Maine , May 05, 2020 (GLOBE NEWSWIRE) -- Covetrus (NASDAQ: CVET), a global leader in animal-health technology and services, announced today that it will release first quarter 2020 financial results after the market close on Thursday, May 14, 2020 .

Strengthened financial profile provides additional resources to execute Covetrus’ strategic growth objectives while navigating COVID-19 pandemic PORTLAND, Maine , April 30, 2020 (GLOBE NEWSWIRE) -- Covetrus (NASDAQ: CVET), a global leader in animal-health technology and services, announced today a

Operationally, all of the company's distribution centers and pharmacies currently remain open, as veterinary medicine has been deemed an essential service in most geographies around the globe Preliminary first quarter net sales of approximately $1.07 billion , an increase of 13% year-over-year;

New functionality allows veterinarians to leverage their existing Covetrus software and services to maintain continuity of care through COVID-19 and beyond PORTLAND, Maine --(BUSINESS WIRE)--Apr. 13, 2020-- Covetrus (NASDAQ: CVET), a global leader in animal-health technology and services, announced

PORTLAND, Maine --(BUSINESS WIRE)--Apr. 1, 2020-- Covetrus ® (NASDAQ: CVET), a global leader in animal-health technology and services, today announced that it has completed the sale of its scil animal care business (“scil”) to Heska Corporation (“Heska”) (NASDAQ: HSKA).

The company’s platform continues to help veterinarians maintain continuity of care for their pet and horse owner clients during this crisis PORTLAND, Maine --(BUSINESS WIRE)--Mar. 23, 2020-- Covetrus (NASDAQ: CVET), a global leader in animal-health technology and services, today shared that the

Sharon Wienbar Nominated to Board of Directors PORTLAND, Maine --(BUSINESS WIRE)-- Covetrus ™ (NASDAQ:CVET), a global leader in animal-health technology and services, today announced that David E. Shaw has informed the company that he will not stand for re-election at the company’s annual meeting

Board of directors announces acting chief executive officer Benjamin Wolin to serve as president and CEO   Fourth quarter net sales of $1.0 billion , an increase of 12% year-over-year; non-GAAP pro forma organic net sales increased 4% year-over-year   Fourth quarter net loss of $37 million ;

Covetrus to Present at the Raymond James 41st Annual Institutional Investor Conference PORTLAND, Maine , Feb. 27, 2020 (GLOBE NEWSWIRE) -- Covetrus (NASDAQ: CVET), a global leader in animal-health technology and services, announced today that it will release fourth quarter and full year 2019

Covetrus Script Assist helps veterinarians enhance patient compliance PORTLAND, Maine --(BUSINESS WIRE)--Jan. 16, 2020-- Covetrus ™ (NASDAQ: CVET), a global leader in animal-health technology and services, today announced the availability of Covetrus Script Assist, a new and more convenient way for